Related Experiment Video

Updated: Jan 21, 2026

A Method to Quantify Visual Information Processing in Children Using Eye Tracking
09:47

A Method to Quantify Visual Information Processing in Children Using Eye Tracking

Published on: July 9, 2016

18.1K

Validation of the Pediatric Eye Questionnaire in Children with Visual Impairment

David A Leske1, Sarah R Hatt1, Yolanda S Castañeda2

  • 1Department of Ophthalmology, Mayo Clinic, Rochester, Minnesota, USA.

American Journal of Ophthalmology
|August 5, 2019
PubMed

Insights

The Pediatric Eye Questionnaire (PedEyeQ) effectively validated its use in visually impaired children, showing lower scores across key domains compared to normal-vision peers. This confirms PedEyeQ

Area of Science:

  • Ophthalmology and Vision Science
  • Pediatric Health
  • Psychometrics and Health Outcomes Measurement

Background:

  • Assessing the quality of life and functional vision in children with visual impairments is crucial for targeted interventions.
  • Existing tools may not adequately capture the unique experiences of visually impaired children and their families.
  • The Pediatric Eye Questionnaire (PedEyeQ) was developed to address this need.

Purpose of the Study:

  • To perform an initial validation of the newly developed Pediatric Eye Questionnaire (PedEyeQ).
  • To evaluate the PedEyeQ's performance in both visually impaired and visually normal pediatric populations.
  • To establish the known-group validity of the PedEyeQ.

Main Methods:

  • A cross-sectional questionnaire validation study involving 48 visually impaired children and 59 visually normal controls aged 5 to 17 years.
  • Children completed age-specific Child PedEyeQ versions (5-11 and 12-17 years).
  • Parents completed Proxy PedEyeQ (0-4, 5-11, 12-17 years) and Parent PedEyeQ versions. Rasch analysis was used to calculate domain scores, which were compared between groups.

Main Results:

  • Visually impaired children scored significantly lower (indicating worse outcomes) than controls across most Child PedEyeQ domains (P < .007).
  • Proxy and Parent PedEyeQ scores were also significantly lower for visually impaired children and their parents across all domains (P < .001).
  • The social domain in 5-11-year-olds was an exception, showing no significant difference between groups (P = .13).

Conclusions:

  • The PedEyeQ demonstrated known-group validity, accurately differentiating between visually impaired and visually normal children.
  • Lower scores in visually impaired children and their parents highlight the impact of visual impairment on functional vision and quality of life.
  • The findings support the PedEyeQ as a valuable tool for assessing eye-related quality of life in pediatric populations.
Abstract

More Related Videos

Gaze in Action: Head-mounted Eye Tracking of Children's Dynamic Visual Attention During Naturalistic Behavior07:09

Gaze in Action: Head-mounted Eye Tracking of Children's Dynamic Visual Attention During Naturalistic Behavior

Published on: November 14, 2018

11.4K
Guidelines for Elective Pediatric Fiberoptic Intubation11:19

Guidelines for Elective Pediatric Fiberoptic Intubation

Published on: January 17, 2011

18.4K

Related Concept Videos

Reliability and Validity01:29

Reliability and Validity

Reliability and validity are two important considerations that must be made with any type of data collection. Reliability refers to the ability to consistently produce a given result. In the context of psychological research, this would mean that any instruments or tools used to collect data do so in consistent, reproducible ways.
13.8K
Data Validation01:03

Data Validation

Data validation is an essential part of a comprehensive assessment. Validation is confirming or verifying and opening the door to gathering more assessment data as it clarifies vague or unclear data. The process of checking and verifying the collected information is called data validation. The primary purpose of data validation is to ensure data is as free from error, bias, and misinterpretation as possible.
Nursing assessment guides are generally based on holistic models rather than medical...
6.3K
Data Validation01:15

Data Validation

Method validation is a crucial process in analytical chemistry designed to confirm that a given method consistently produces reliable and high-quality results. This process is essential when a method is applied to different sample matrices or when procedural modifications are made, ensuring that the results meet acceptable standards across various applications.
Key parameters for method validation include:
583
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
214
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
433
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
263